Growth Outlook: Hemato Oncology Testing Market Is Booming Across the Globe by 2019 - 2027
Hematologic malignancies are amongst the top ten malignant disorders with respect to the incidence rate as well as cause of death in patients suffering from cancer. Collectively, they constitute approximately 9% of all cancer cases diagnosed in a year. Geneticists are providing Hemato oncologists with not only diagnostic tests but also key knowledge of cancer genetics which helps the specialist assess prognosis of their patient, select the most appropriate anticancer therapy, and monitor the response to treatment. Generally, peripheral blood lymphocyte culture is used for diagnosis of non-malignant genetic disorders.
View Report: https://www.transparencymarketresearch.com/hemato-oncology-testing-market.html
The cells are cultured in a favorable media using T lymphocyte mitogens like phytohemagglutinin (PHA) to enhance the mitotic division and abundant metaphases are obtained. However, malignant cells from bone marrow or peripheral blood are used for identification of cytogenetic abnormalities in hematological malignancies, wherein the yield of metaphases may be suboptimal. Cytogenetic analysis of chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) patients is often difficult because of the low proliferating rate of the malignant cells and the presence of normal cells in bone marrow which may interfere with their growth rate. In such cases, TPA (12-O-tetradecanoylphorbol 13-acetate) stimulated cultures are used to improve the yield of metaphases.
Global Hemato Oncology Testing Market: Competitive Landscape
Hoffmann-La Roche Ltd
Hoffmann-La Roche Ltd is a prominent global biotech company that engages in the development, manufacture, marketing, and sale of biopharmaceutical products and services. The company operates through three major segments: Pharmaceuticals, Diagnostic Solutions, and Products for Researchers. F. Hoffmann-La Roche Ltd operates in more than 100 countries through a wide distribution network and its own sales team.
Abbott Laboratories is a global health care solutions provider engaged in discovery, development, production, and sale of diversified health care products.
The company provides a wide range of diagnostic and medical test instruments that are used across the globe by various end-users to diagnose and monitor coagulation systems, cancer, heart diseases, and metabolic disorders; and assess other health indicators.
Abbott Laboratories is a leader in making microfluidic devices and techniques such as point-of-care diagnostics, immunoassays for blood screening, and laboratory tools. The company provides services in about 150 countries and has around 94,000 employees.
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific is a global leader in development, manufacturing, and commercialization of life sciences products for health care, pharmaceutical & biotechnology, and life sciences industries. Thermo Fisher Scientific, Inc. operates through four segments: Specialty Diagnostics, Analytical Instruments, Life Sciences Solutions, and Laboratory Products and Services. The specialty diagnostics segment offers a wide range of instruments, kits, and reagents for customers in health care, academic institutes, and other service providers. The segment comprises clinical diagnostics, immunodiagnostics, microbiology, and other businesses. Thermo Fisher Scientific offers products and services to more than 400,000 customers across the globe.
For More Details, Request A PDF Brochure Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=71694
Global Hemato Oncology Testing Market: Dynamics
Rise in Prevalence of Lymphoma & Myeloma Cancers
Multiple myeloma is the third most common form of hematological malignancy after non-Hodgkin’s lymphoma and leukemia and is characterized by uncontrolled proliferation of a clone of plasma cells within the bone marrow. According to the Leukemia & Lymphoma Society (LLS), around 176,200 people in the U.S. are expected to be diagnosed with leukemia, lymphoma, or myeloma in 2019. New cases of leukemia, lymphoma, and myeloma are anticipated to account for 10% of the estimated 1,762,450 new cancer cases diagnosed in the U.S. in 2019. Prevalence is the approximate number of people alive on a certain date in a population who previously had a diagnosis of the disease. An estimated 1,399,180 people in the U.S. are either living with, or are in remission from, leukemia, lymphoma, or myeloma.
Growing Focus on Personalized Medicine
The concepts of Personalized Medicines-PM have been subtly appreciated in medicine since the 1960s with its first mention in a monograph title in 1998 and subsequent publication on the Medline interface in 1999. Advancement in genetic technologies, primarily; single nucleotide polymorphism (SNP) genotyping and microarray/biochips has been the pillar and drive toward PM.
Global Hemato Oncology Testing Market: Segmentation
Based on product & services, the global hemato oncology testing Market can be bifurcated into:
In terms of cancer, the global Hemato oncology testing market can be divided into:
Based on technology, the global Hemato oncology testing market can be categorized into:
PCR-Polymerase Chain Reaction
NGS- Next-generation sequencing
In terms of end-users, the global hemato oncology testing market can be classified into:
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Growth Outlook: Hemato Oncology Testing Market Is Booming Across the Globe by 2019 - 2027 here
News-ID: 1894855 • Views: 297
More Releases from TMR
Protection Relay Market: Growth Trends, Opportunities, Revenue, Industry Demand …
Transparency Market Research delivers key insights on the global protection relay market. In terms of revenue, the global protection relay market is estimated to expand at a CAGR of ~9% during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in its report on the global protection relay market. A protection relay is a device designed to trip a circuit breaker when fault is detected
SD-WAN Market: Comprehensive Analysis Of The Current Trends And Inclinations, Al …
The market for SD-WAN, acronym for software-defined wide area network, holds massive potential. It is highly competitive on account of savvy players launching more cutting-edge products every now and then. The players are also seen to be leveraging strategic partnerships to enhance their positions further. Some are offering both on-premise and could-based WAN management solutions to tap into more service providers and large companies. Some of the prominent participants in the
AI in Medical Imaging Market: Study Provides In-Depth Analysis Of Market Along W …
According to a new market report pertaining to the global AI in medical imaging market published by Transparency Market Research the global AI in medical imaging market is anticipated to reach ~US$ 7.4 Bn by 2027. The market is projected to expand at a CAGR of ~45% from 2019 to 2027 in terms of revenue. According to the report, North America was the largest contributor in terms of revenue to
On-the-go Breakfast Packaging Market: Overview And In-Depth Analysis With Top Ke …
The global on-the-go breakfast packaging market is expected to be a host to an intensely competitive business landscape, reports Transparency Market Research (TMR). Featuring high fragmentation, the global on-the-go breakfast packaging market comprises a large pool of both small- and medium-sized vendors. Established vendors are seen expanding their product portfolios in order to keep their presence dominant in the market. The emergence of flexible packaging materials and further advances in
More Releases for Hemato
Global Hemato Oncology Testing Market with Current Trends Analysis, 2020-2026| Z …
The "Global Hemato Oncology Testing Market with Current Trends Analysis, 2020-2026| Zion Market Research" distributed and advanced by Zion Market Research gives inside and out portion investigation of the Hemato Oncology Testing Market being compelling in a few areas, in this manner giving significant bits of knowledge to the opponents. The Hemato Oncology Testing Market report that features the worldwide Hemato Oncology Testing Market confers the crowds with an extensive
Hemato Oncology Testing Market Overview by Increasing Demands and Sales 2021 to …
Hemato Oncology Testing Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and discussion of important industry like market trends, size, share, growth estimates are mentioned in the report. The "Global Hemato Oncology Testing Market Analysis to 2027" is a specialized and in-depth study
Hemato Oncology Testing Market Is Expected To Reach $8.9 Billion by 2031, Growth …
According to a new market research report published by sheer analytics and insights, “The Global Hemato Oncology Testing Market was valued at $2.2 Billion in 2020. Growing at a high CAGR of more than 13.3% between 2021 and 2031, it is estimated to reach $8.9 Billion by 2031”, as per the latest market research report titled, Global Hemato Oncology Testing Market - Industry analysis, size, share, growth, trends, and forecast,
Global Hemato Oncology Testing Market | GME
As per the latest research findings by GME, the Hemato Oncology Testing Market will grow speedily at a 13.8% CAGR rate from the 2020 to 2026 forecast period. The demand for hemato oncology testing is projected due to the increasing number of patients clubbed with rising demand for customized medicines Browse 158 Market Data Tables and 119 Figures spread through 185 Pages and in-depth TOC on "Hemato Oncology Testing Market -
Global Hemato Oncology Testing Market Set for Rapid Growth in the Forecast Perio …
Zion Market Research Reports added Latest Research Report titled “Global Hemato Oncology Testing Market Set for Rapid Growth in the Forecast Period 2020–2026 - Zion Market Research″ to its Large Report database. This report gives detailed survey of the market by examining changing aggressive elements of the Hemato Oncology Testing Market. It helps in understanding the key product sectors and their future. It gives pin point analysis of changing rivalry
Releases New Report on the Hemato Oncology Testing Market 2020-2025 | Top Key Pl …
Global Hemato Oncology Testing Market Synopsis: The report covers a forecast and an analysis of the Hemato Oncology Testing Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Hemato Oncology Testing Market along with the impact they have